AustriaA study conducted in Vienna involving swallowable gastric balloons for treating obesity was prematurely halted due to severe side effects in two out of five patients. Four out of ten balloons caused membrane damage, while two cases resulted in small bowel obstruction requiring emergency surgery. The researchers concluded that the product is currently unsuitable for clinical practice, although the manufacturer is working on modifying the balloon design. The study aimed to test a new medical device where balloons would expand in the stomach to create a feeling of fullness. Previous treatments included gastric bands and silicone balloons inserted via endoscopy. Newer approaches include medications like GLP-1 receptor agonists, but mechanical methods continue to evolve. The study involved patients with a BMI over 35 or 30 with comorbidities, starting with five participants and planned to expand to 20.
Bias read (Center): The article presents a balanced report on a medical study, focusing on scientific findings and expert opinions without overtly favoring any political ideology. It discusses both the limitations of current treatments and the ongoing development of new medical devices, maintaining neutrality in its ph
